Status:
COMPLETED
A Prospective Controlled Study on Treatment of Giant Cavernous Hemangiomas of the Liver
Lead Sponsor:
Southwest Hospital, China
Conditions:
Laparoscopic Hepatectomy
Radio-frequency Ablation
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
In the past, the investigators often treated giant cavernous hemangiomas of the liver by hepatectomy.Recently RFA and laparoscopic hepatectomy are also available and could be applied to cure this dise...
Eligibility Criteria
Inclusion
- giant cavernous hemangiomas with a diameter larger than or equal to 5 cm diagnosed by more than one imaging modalities
- age between 18 years to 65 years
- without gender restriction
- PLT account more than 50 e9
- without abnormal of liver function test
- with substantial evidence of growing size than before
- symptom associated cavernous hemangiomas
- with a strong desire of the patients for the treatment
Exclusion
- pregnant women
- abnormal of liver function or coagulation dysfunction and/or concurrent with sever cardiac or pulmonary disorders
- patient with a poor condition that can't bear the approach of either RFA or laparoscopic hepatectomy
- tumor size more than 20cm
Key Trial Info
Start Date :
November 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2014
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT01471080
Start Date
November 1 2011
End Date
January 1 2014
Last Update
July 2 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of hepatobiliary surgery,southwest hospital
Chongqing, Chongqing Municipality, China, 400038